LGM

Logos Global Management Portfolio holdings

AUM $749M
1-Year Return 18.94%
This Quarter Return
+49.51%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$811M
AUM Growth
+$266M
Cap. Flow
+$84.2M
Cap. Flow %
10.39%
Top 10 Hldgs %
63.24%
Holding
45
New
13
Increased
4
Reduced
11
Closed
7

Top Buys

1
ALLK
Allakos
ALLK
$36.3M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$26.9M
3
ASND icon
Ascendis Pharma
ASND
$25.8M
4
VRDN icon
Viridian Therapeutics
VRDN
$20.5M
5
XENE icon
Xenon Pharmaceuticals
XENE
$18.1M

Top Sells

1
VTYX icon
Ventyx Biosciences
VTYX
$31.9M
2
NBIX icon
Neurocrine Biosciences
NBIX
$29.2M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$27.9M
4
CCXI
ChemoCentryx, Inc.
CCXI
$14.9M
5
APLS icon
Apellis Pharmaceuticals
APLS
$13.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KZR icon
26
Kezar Life Sciences
KZR
$28M
$8.18M 1.01%
95,000
– –
CMPS
27
Compass Pathways
CMPS
$489M
$5.47M 0.67%
+510,000
New +$5.47M
GERN icon
28
Geron
GERN
$880M
$4.68M 0.58%
+2,000,000
New +$4.68M
IPSC icon
29
Century Therapeutics
IPSC
$41.4M
$4.55M 0.56%
460,075
-16,484
-3% -$163K
VIGL
30
DELISTED
Vigil Neuroscience
VIGL
$1.87M 0.23%
205,595
– –
CNTA
31
Centessa Pharmaceuticals
CNTA
$2.12B
$1.61M 0.2%
399,801
– –
TIL icon
32
Instil Bio
TIL
$205M
$1.61M 0.2%
16,594
-1,896
-10% -$183K
SPRB
33
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$1.37M 0.17%
1,000,000
– –
TYRA icon
34
Tyra Biosciences
TYRA
$647M
$1.12M 0.14%
127,316
-39,210
-24% -$345K
LIAN
35
DELISTED
LianBio American Depositary Shares
LIAN
$616K 0.08%
307,908
-86,578
-22% -$173K
TRML icon
36
Tourmaline Bio
TRML
$645M
$521K 0.06%
19,791
-7,308
-27% -$192K
PYXS icon
37
Pyxis Oncology
PYXS
$99.8M
$434K 0.05%
220,434
– –
NUVB.WS icon
38
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$71.3M
$13K ﹤0.01%
66,666
– –
ACAD icon
39
Acadia Pharmaceuticals
ACAD
$4.3B
– –
-650,000
Closed -$9.16M
ATHA icon
40
Athira Pharma
ATHA
$15.3M
– –
-220,000
Closed -$671K
EWTX icon
41
Edgewise Therapeutics
EWTX
$1.54B
– –
-150,000
Closed -$1.19M
NBIX icon
42
Neurocrine Biosciences
NBIX
$13.9B
– –
-300,000
Closed -$29.2M
NUVL icon
43
Nuvalent
NUVL
$5.74B
– –
-33,887
Closed -$460K
CCXI
44
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-600,000
Closed -$14.9M
HZNP
45
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-350,000
Closed -$27.9M
1
2